Annual EBIT
-$23.71 M
-$11.42 M-92.91%
December 31, 2023
Summary
- As of March 4, 2025, OPRX annual earnings before interest & taxes is -$23.71 million, with the most recent change of -$11.42 million (-92.91%) on December 31, 2023.
- During the last 3 years, OPRX annual EBIT has fallen by -$21.57 million (-1010.38%).
- OPRX annual EBIT is now -3109.65% below its all-time high of $787.80 thousand, reached on December 31, 2018.
Performance
OPRX EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
-$8.42 M
-$4.85 M-135.90%
September 30, 2024
Summary
- As of March 4, 2025, OPRX quarterly earnings before interest & taxes is -$8.42 million, with the most recent change of -$4.85 million (-135.90%) on September 30, 2024.
- Over the past year, OPRX quarterly EBIT has stayed the same.
- OPRX quarterly EBIT is now -720.49% below its all-time high of $1.36 million, reached on December 31, 2020.
Performance
OPRX Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
-$27.28 M
-$5.55 M-25.55%
September 30, 2024
Summary
- As of March 4, 2025, OPRX TTM earnings before interest & taxes is -$27.28 million, with the most recent change of -$5.55 million (-25.55%) on September 30, 2024.
- Over the past year, OPRX TTM EBIT has stayed the same.
- OPRX TTM EBIT is now -2388.78% below its all-time high of $1.19 million, reached on June 30, 2019.
Performance
OPRX TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
OPRX EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -92.9% | 0.0% | 0.0% |
| 3 y3 years | -1010.4% | -1455.2% | -7654.7% |
| 5 y5 years | -3109.7% | -454.2% | -803.4% |
OPRX EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -6666.1% | at low | -1455.2% | +18.2% | -7654.7% | at low |
| 5 y | 5-year | -6666.1% | at low | -720.5% | +18.2% | -2587.9% | at low |
| alltime | all time | -3109.7% | at low | -720.5% | +18.2% | -2388.8% | at low |
OptimizeRx EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$8.42 M(+135.9%) | -$27.28 M(+25.6%) |
| Jun 2024 | - | -$3.57 M(-28.8%) | -$21.73 M(-2.5%) |
| Mar 2024 | - | -$5.01 M(-51.3%) | -$22.29 M(-5.9%) |
| Dec 2023 | -$23.71 M(+92.9%) | -$10.29 M(+259.0%) | -$23.68 M(+66.1%) |
| Sep 2023 | - | -$2.87 M(-30.6%) | -$14.26 M(-5.9%) |
| Jun 2023 | - | -$4.13 M(-35.5%) | -$15.15 M(+1.5%) |
| Mar 2023 | - | -$6.40 M(+640.3%) | -$14.93 M(+21.5%) |
| Dec 2022 | -$12.29 M(-3503.7%) | -$864.30 K(-77.0%) | -$12.29 M(+13.7%) |
| Sep 2022 | - | -$3.76 M(-3.9%) | -$10.81 M(+54.1%) |
| Jun 2022 | - | -$3.91 M(+3.9%) | -$7.01 M(+153.8%) |
| Mar 2022 | - | -$3.76 M(-705.6%) | -$2.76 M(-864.8%) |
| Dec 2021 | $361.10 K(-116.9%) | $621.10 K(+1525.9%) | $361.10 K(-67.1%) |
| Sep 2021 | - | $38.20 K(-88.8%) | $1.10 M(+24.4%) |
| Jun 2021 | - | $340.10 K(-153.3%) | $881.60 K(-271.4%) |
| Mar 2021 | - | -$638.30 K(-147.1%) | -$514.30 K(-75.9%) |
| Dec 2020 | -$2.14 M(-26.2%) | $1.36 M(-867.7%) | -$2.14 M(-57.4%) |
| Sep 2020 | - | -$176.70 K(-83.3%) | -$5.01 M(-26.5%) |
| Jun 2020 | - | -$1.06 M(-53.3%) | -$6.82 M(+29.1%) |
| Mar 2020 | - | -$2.26 M(+48.8%) | -$5.29 M(+75.0%) |
| Dec 2019 | -$2.89 M(-467.3%) | -$1.52 M(-23.6%) | -$3.02 M(+183.7%) |
| Sep 2019 | - | -$1.99 M(-514.0%) | -$1.06 M(-189.3%) |
| Jun 2019 | - | $480.00 K(+7284.6%) | $1.19 M(+20.9%) |
| Mar 2019 | - | $6500.00(-98.5%) | $985.50 K(+24.8%) |
| Dec 2018 | $787.80 K(-137.0%) | $436.60 K(+62.4%) | $789.80 K(+775.6%) |
| Sep 2018 | - | $268.80 K(-1.8%) | $90.20 K(-111.3%) |
| Jun 2018 | - | $273.60 K(-244.6%) | -$801.40 K(-44.2%) |
| Mar 2018 | - | -$189.20 K(-28.1%) | -$1.44 M(-32.6%) |
| Dec 2017 | -$2.13 M(+38.4%) | -$263.00 K(-57.8%) | -$2.13 M(-4.0%) |
| Sep 2017 | - | -$622.80 K(+72.3%) | -$2.22 M(+20.7%) |
| Jun 2017 | - | -$361.50 K(-59.0%) | -$1.84 M(-11.1%) |
| Mar 2017 | - | -$882.70 K(+150.1%) | -$2.07 M(+34.5%) |
| Dec 2016 | -$1.54 M | -$352.90 K(+45.5%) | -$1.54 M(-3.9%) |
| Sep 2016 | - | -$242.60 K(-59.0%) | -$1.60 M(+26.0%) |
| Jun 2016 | - | -$591.90 K(+68.2%) | -$1.27 M(+52.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2016 | - | -$351.80 K(-15.2%) | -$835.80 K(+40.4%) |
| Dec 2015 | -$595.10 K(-42.0%) | -$414.70 K(-571.8%) | -$595.20 K(+70.5%) |
| Sep 2015 | - | $87.90 K(-155.9%) | -$349.00 K(-52.3%) |
| Jun 2015 | - | -$157.20 K(+41.4%) | -$731.70 K(-5.5%) |
| Mar 2015 | - | -$111.20 K(-34.0%) | -$774.40 K(-24.5%) |
| Dec 2014 | -$1.03 M(+283.6%) | -$168.50 K(-42.8%) | -$1.03 M(+39.6%) |
| Sep 2014 | - | -$294.80 K(+47.5%) | -$734.30 K(+26.4%) |
| Jun 2014 | - | -$199.90 K(-44.8%) | -$581.10 K(+106.5%) |
| Mar 2014 | - | -$362.20 K(-395.4%) | -$281.40 K(+95.8%) |
| Dec 2013 | -$267.30 K(-41.2%) | $122.60 K(-186.6%) | -$143.70 K(-39.6%) |
| Sep 2013 | - | -$141.60 K(-241.9%) | -$237.90 K(+17.5%) |
| Jun 2013 | - | $99.80 K(-144.5%) | -$202.40 K(-46.5%) |
| Mar 2013 | - | -$224.50 K(-890.5%) | -$378.40 K(-16.8%) |
| Dec 2012 | -$454.50 K(-60.9%) | $28.40 K(-126.8%) | -$454.80 K(-21.1%) |
| Sep 2012 | - | -$106.10 K(+39.2%) | -$576.30 K(-34.5%) |
| Jun 2012 | - | -$76.20 K(-74.7%) | -$879.20 K(-28.1%) |
| Mar 2012 | - | -$300.90 K(+223.2%) | -$1.22 M(+5.2%) |
| Dec 2011 | -$1.16 M(-38.9%) | -$93.10 K(-77.2%) | -$1.16 M(-12.7%) |
| Sep 2011 | - | -$409.00 K(-2.6%) | -$1.33 M(-6.7%) |
| Jun 2011 | - | -$420.10 K(+75.1%) | -$1.43 M(-24.2%) |
| Mar 2011 | - | -$239.90 K(-8.5%) | -$1.88 M(-1.2%) |
| Dec 2010 | -$1.90 M(-58.2%) | -$262.30 K(-48.0%) | -$1.90 M(-52.1%) |
| Sep 2010 | - | -$504.60 K(-42.3%) | -$3.97 M(-2.7%) |
| Jun 2010 | - | -$874.70 K(+234.1%) | -$4.08 M(+15.0%) |
| Mar 2010 | - | -$261.80 K(-88.8%) | -$3.55 M(-23.6%) |
| Dec 2009 | -$4.55 M(+7.2%) | -$2.33 M(+279.9%) | -$4.65 M(-22.5%) |
| Sep 2009 | - | -$613.40 K(+79.3%) | -$5.99 M(+8.2%) |
| Jun 2009 | - | -$342.10 K(-74.9%) | -$5.54 M(+2.6%) |
| Mar 2009 | - | -$1.36 M(-63.0%) | -$5.40 M(+26.9%) |
| Dec 2008 | -$4.25 M(+1093.6%) | -$3.68 M(+2179.0%) | -$4.26 M(+635.1%) |
| Sep 2008 | - | -$161.40 K(-20.2%) | -$579.20 K(+38.6%) |
| Jun 2008 | - | -$202.20 K(-6.2%) | -$417.80 K(+93.8%) |
| Mar 2008 | - | -$215.60 K | -$215.60 K |
| Dec 2007 | -$355.90 K | - | - |
FAQ
- What is OptimizeRx annual earnings before interest & taxes?
- What is the all time high annual EBIT for OptimizeRx?
- What is OptimizeRx annual EBIT year-on-year change?
- What is OptimizeRx quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for OptimizeRx?
- What is OptimizeRx quarterly EBIT year-on-year change?
- What is OptimizeRx TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for OptimizeRx?
- What is OptimizeRx TTM EBIT year-on-year change?
What is OptimizeRx annual earnings before interest & taxes?
The current annual EBIT of OPRX is -$23.71 M
What is the all time high annual EBIT for OptimizeRx?
OptimizeRx all-time high annual earnings before interest & taxes is $787.80 K
What is OptimizeRx annual EBIT year-on-year change?
Over the past year, OPRX annual earnings before interest & taxes has changed by -$11.42 M (-92.91%)
What is OptimizeRx quarterly earnings before interest & taxes?
The current quarterly EBIT of OPRX is -$8.42 M
What is the all time high quarterly EBIT for OptimizeRx?
OptimizeRx all-time high quarterly earnings before interest & taxes is $1.36 M
What is OptimizeRx quarterly EBIT year-on-year change?
Over the past year, OPRX quarterly earnings before interest & taxes has changed by $0.00 (0.00%)
What is OptimizeRx TTM earnings before interest & taxes?
The current TTM EBIT of OPRX is -$27.28 M
What is the all time high TTM EBIT for OptimizeRx?
OptimizeRx all-time high TTM earnings before interest & taxes is $1.19 M
What is OptimizeRx TTM EBIT year-on-year change?
Over the past year, OPRX TTM earnings before interest & taxes has changed by $0.00 (0.00%)